These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10931372)

  • 1. Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival.
    Varlet P; Guillamo JS; Nataf F; Koziak M; Beuvon F; Daumas-Duport C
    Neuropathol Appl Neurobiol; 2000 Aug; 26(4):379-89. PubMed ID: 10931372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
    Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
    Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases.
    Korshunov A; Golanov A
    J Neurooncol; 2000 May; 48(1):13-9. PubMed ID: 11026692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas.
    Vaquero J; Zurita M; Coca S; Oya S; Morales C
    Surg Neurol; 2000 Sep; 54(3):229-34; discussion 234. PubMed ID: 11118569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reappraisal of the Sainte-Anne Hospital classification of oligodendrogliomas in view of retrospective studies].
    Daumas-Duport C; Koziak M; Miquel C; Nataf F; Jouvet A; Varlet P
    Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):247-53. PubMed ID: 16292168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of tumor angiogenesis as a prognostic factor of survival in patients with oligodendroglioma.
    Quon H; Hasbini A; Cougnard J; Djafari L; Lacroix C; Abdulkarim B
    J Neurooncol; 2010 Jan; 96(2):277-85. PubMed ID: 19618120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma.
    Deininger MH; Weller M; Streffer J; Meyermann R
    Cancer; 1999 Nov; 86(9):1832-9. PubMed ID: 10547558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and distribution of vascular endothelial growth factor protein in human brain tumors.
    Pietsch T; Valter MM; Wolf HK; von Deimling A; Huang HJ; Cavenee WK; Wiestler OD
    Acta Neuropathol; 1997 Feb; 93(2):109-17. PubMed ID: 9039457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclin A and topoisomerase IIalpha of oligodendrogliomas is correlated with tumour grade, MIB-1 labelling index and survival.
    Park SH; Suh YL
    Histopathology; 2003 Apr; 42(4):395-402. PubMed ID: 12653952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor and p53 protein in association with neovascularization in human malignant gliomas.
    Miyagami M; Tazoe M; Nakamura S
    Brain Tumor Pathol; 1998; 15(2):95-100. PubMed ID: 10328546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas.
    Christov C; Adle-Biassette H; Le Guerinel C; Natchev S; Gherardi RK
    Neuropathol Appl Neurobiol; 1998 Feb; 24(1):29-35. PubMed ID: 9549726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
    Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
    J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas.
    Chaudhry IH; O'Donovan DG; Brenchley PE; Reid H; Roberts IS
    Histopathology; 2001 Oct; 39(4):409-15. PubMed ID: 11683943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
    Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
    J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical markers for prognosis of oligodendroglial neoplasms.
    Korshunov A; Golanov A; Sycheva R
    J Neurooncol; 2002 Jul; 58(3):237-53. PubMed ID: 12187958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of meningiomas.
    Yamasaki F; Yoshioka H; Hama S; Sugiyama K; Arita K; Kurisu K
    Cancer; 2000 Sep; 89(5):1102-10. PubMed ID: 10964341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours.
    Yao Y; Kubota T; Sato K; Kitai R; Takeuchi H; Arishima H
    Acta Neurochir (Wien); 2001; 143(2):159-66. PubMed ID: 11459088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria.
    Daumas-Duport C; Tucker ML; Kolles H; Cervera P; Beuvon F; Varlet P; Udo N; Koziak M; Chodkiewicz JP
    J Neurooncol; 1997 Aug; 34(1):61-78. PubMed ID: 9210053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.
    Kros JM; Hop WC; Godschalk JJ; Krishnadath KK
    Cancer; 1996 Sep; 78(5):1107-13. PubMed ID: 8780550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade 2 oligodendroglioma.
    Reis-Filho JS; Faoro LN; Carrilho C; Bleggi-Torres LF; Schmitt FC
    Cancer; 2000 Feb; 88(4):862-9. PubMed ID: 10679656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.